The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Understand the problem first: Read the question carefully, identify inputs, outputs, and constraints before writing any code to avoid confusion and mistakes. Break complex problems into small steps: ...

Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise of future Omnipod innovation to address unmet needs, improve ...

The Harris Poll’s TikTok Troubles: The Platform Gen Z Can’t Quit (But Doesn’t Trust) report, conducted this month, found that a strong majority of young adults continue to use the app daily, but their ...

Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...

Gen Z is turning their backs on social media except for this one app – and they don’t necessarily trust it - Over half of Gen Z say TikTok is straight-up sus and trust it less than before ...

Researchers in China have developed magnetically controlled microrobots made from diatoms for the treatment of glioblastoma using photodynamic therapy. These microrobots exhibit excellent magnetic ...

At Pittcon 2026 in San Antonio, Texas, the LCGC International Awards Session was held on Tuesday, March 10, from 1:30 PM to 4:40 PM. This session, presided by Jerome Workman, Jr., celebrated two ...

AI adoption in healthcare revenue cycle is accelerating, but a widening trust gap is preventing organizations from moving beyond pilots.

Gary Marcus discusses if the strike on a school in Iran stems from the use of artificial intelligence in the war.